Related Experiment Video
Updated: Jun 28, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Underestimation of Invasive Meningococcal Disease in Italy
Abstract:
Knowing the incidence of invasive meningococcal disease (IMD) is essential for planning appropriate vaccination policies. However, IMD may be underestimated because of misdiagnosis or insufficiently sensitive laboratory methods. Using a national molecular surveillance register, we assessed the number of cases misdiagnosed and diagnoses obtained postmortem with real-time PCR (rPCR), and we compared sensitivity of rPCR versus culture-based testing. A total of 222 IMD cases were identified: 11 (42%) of 26 fatal cases had been misdiagnosed or undiagnosed and were reclassified as IMD after rPCR showed meningococcal DNA in all available specimens taken postmortem. Of the samples tested with both rPCR and culture, 58% were diagnosed by using rPCR alone. The underestimation factor associated with the use of culture alone was 3.28. In countries such as Italy, where rPCR is in limited use, IMD incidence may be largely underestimated; thus, assessments of benefits of meningococcal vaccination may be prone to error.
Insights
Invasive meningococcal disease (IMD) is often underestimated due to misdiagnosis and limited lab sensitivity. Real-time PCR (rPCR) significantly improves IMD case detection, especially in postmortem samples.
Area of Science:
- Microbiology
- Epidemiology
- Vaccinology
Background:
- Accurate incidence data for invasive meningococcal disease (IMD) is crucial for effective vaccination policy development.
- Current diagnostic methods, primarily culture-based, may underestimate IMD prevalence due to limitations in sensitivity and potential for misdiagnosis.
Observation:
- A national molecular surveillance register utilizing real-time PCR (rPCR) was employed to re-evaluate IMD cases.
- The study assessed misdiagnosed cases, postmortem diagnoses, and compared the sensitivity of rPCR against traditional culture methods.
Findings:
- Out of 26 fatal cases, 11 (42%) were initially misdiagnosed or undiagnosed, with rPCR confirming meningococcal DNA in postmortem specimens.
- Real-time PCR alone diagnosed 58% of samples that were negative by culture-based methods.
- Culture-based testing alone resulted in an underestimation factor of 3.28 for IMD incidence.
Implications:
- The widespread underestimation of IMD incidence in regions with limited rPCR use, such as Italy, can lead to inaccurate assessments of meningococcal vaccine efficacy and public health impact.
- Implementing molecular diagnostic tools like rPCR is essential for precise IMD surveillance and informed public health strategies.
More Related Videos
07:43Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
09:17A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice
Published on: January 5, 2021
Related Concept Videos
Bias in Epidemiological Studies
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology